MedTrace Logo

Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention

NCT00578396 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2021-01-25

No results posted yet for this study

Summary

This study is designed to investigate the dietary influence of grapes in colon cancer prevention. A natural compound found in the skin of grapes, resveratrol, may protect against cancer by acting as an antioxidant (a chemical compound or substance that helps reduce damages due to oxygen). This compound is known to block colon cancer cell lines from growing in the laboratory. The purpose of this study is to determine the minimum amount of resveratrol-rich fresh red grapes needed to exhibit such signs of prevention.

Conditions

Interventions

DIETARY_SUPPLEMENT

grapes

1 pound of seedless red grapes

DIETARY_SUPPLEMENT

grapes

2/3 lb/day fresh red grapes

DIETARY_SUPPLEMENT

grapes

1/3 lb/day fresh red grapes

Sponsors & Collaborators

  • Gateway for Cancer Research

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Randall F Holcombe, M.D. · University of California, Irvine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00578396 on ClinicalTrials.gov